RETENTION RATES OF ADALIMUMAB, ETANERCEPT, AND INFLIXIMAB AS BIOTHERAPIES FOR RHEUMATOID ARTHRITIS, SPONDYLOARTHRITIS, OR PSORIATIC ARTHRITIS PATIENTS IN DAILY PRACTICE IN AUVERGNE (FRANCE)

被引：0
|
作者：
Soubrier, M. [1 ]
Fan, A. [1 ]
Couderc, M. [1 ]
Malochet-Guinamand, S. [1 ]
Mathieu, S. [1 ]
Giraud, C. [1 ]
Tournadre, A. [1 ]
Dubost, J. -J. [1 ]
Pereira, B. [2 ]
机构：
[1] CHU Clermont Ferrand, Dept Rheumatol, Clermont Ferrand, France
[2] CHU Clermont Ferrand, Biostat Unit, Clermont Ferrand, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.5086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1333
引用
收藏
页码：1756 / 1756
页数：1
相关论文
共 50 条
  • [41] Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab
    Katsicas, Maria M.
    Russo, Ricardo A. G.
    CLINICAL RHEUMATOLOGY, 2009, 28 (08) : 985 - 988
  • [42] The Immunogenicity of Infliximab, Adalimumab and Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Crohn's Disease and Ulcerative Colitis-a Quantitative and a Qualitative Review
    Garces, Sandra
    Demengeot, Jocelyne
    Wolbink, Gj
    Aarden, L.
    Benito-Garcia, Elizabeth
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S178 - S178
  • [43] ETANAR - A ETANERCEPT BIOSIMILAR IS AS EFFECTIVE AS ADALIMUMAB AND INFLIXIMAB IN A COHORT OF REAL-LIFE OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Santos-Moreno, P.
    Saavedra-Martinez, G.
    Villarreal, L.
    Gomez, D.
    Bello-Gualtero, J.
    Giraldo, V.
    Martinez, P.
    Sanchez, A.
    Sanchez, M.
    Uribe, E.
    Boon, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 789 - 790
  • [44] Retention on Adalimumab, Etanercept, Golimumab and Infliximab in Two Eras - Experience of Patients with Rheumatoid Arthritis from a Real-World Database RHUMADATA®
    Choquette, Denis
    Bessette, Louis
    Coupal, Louis
    Garces, Kirsten
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [45] Cost-effectiveness of two TNF inhibitors, etanercept and infliximab, in patients with rheumatoid arthritis in daily clinical practice in the Netherlands
    Creemers, MC
    Kievit, W
    Flendrie, M
    Van den Hoogen, FH
    De Jong, AJ
    Van Riel, PL
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 430 - 430
  • [46] Infection risk in patients with rheumatoid arthritis treated with etanercept or adalimumab
    Chiang, Yi-Chun
    Kuo, Li-Na
    Yen, Yu-Hsuan
    Tang, Chao-Hsiun
    Chen, Hsiang-Yin
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2014, 116 (03) : 319 - 327
  • [47] Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
    Rosalía Martínez-Pérez
    Sergio Rodríguez-Montero
    Alejandro Muñoz
    Julia Uceda
    Mario León
    Francisco Gallo
    Maria Luisa Velloso
    José Luis Marenco
    Journal of Translational Medicine, 9 (Suppl 2)
  • [48] THE EFFECT OF METHOTREXATE IN TREATMENT WITH ADALIMUMAB AND ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    l'Ami, M.
    Kneepkens, E.
    Krieckaert, C.
    Marsman, A.
    Ruwaard, J.
    Wolbink, G.
    Nurmohamed, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 708 - 709
  • [49] COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING
    Gokhale, S. B.
    Cassel, T.
    Mahon, R.
    Balkin, P. E.
    Singh, S.
    Bhattacharyya, S.
    Handin, J.
    Mendoza, C.
    VALUE IN HEALTH, 2016, 19 (07) : A535 - A535
  • [50] DRUG SURVIVAL ON FIRST TNF INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS: COMPARISON ACROSS ETANERCEPT, ADALIMUMAB, GOLIMUMAB AND INFLIXIMAB
    Garcia-Porrua, C.
    Maceiras-Pan, F.
    Fernandez-Dominguez, L.
    Mosquera-Martinez, J. A.
    Correa-Rey, B.
    Pombo-Suarez, M.
    Pinto-Tasende, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1031 - 1031
12345